Heparin‐induced thrombocytopaenia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Live birth · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
Heparin plus aspirin may leads to higher live birth compared with aspirin (low certainty).
1 finding from 1 review
Pre‐eclampsia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
Heparin plus aspirin showed no clear difference in pre‐eclampsia compared with aspirin (low certainty).
1 finding from 1 review
Adverse events in the mother ‐ Bleeding · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
Heparin plus aspirin showed no clear difference in adverse events in the mother ‐ Bleeding compared with aspirin (low certainty).
1 finding from 1 review
Allergic reaction · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Venous thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Arterial thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Pregnancy loss · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
Heparin plus aspirin may leads to lower pregnancy loss compared with aspirin (low certainty).
1 finding from 1 review
Preterm delivery of a live infant · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether heparin plus aspirin changes preterm delivery of a live infant compared with aspirin (very low certainty).
1 finding from 1 review
Intrauterine growth restriction · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether heparin plus aspirin changes intrauterine growth restriction compared with aspirin (very low certainty).
1 finding from 1 review
Adverse events in the child ‐ Congenital malformations · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
1 finding from 1 review
Live birth · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes live birth compared with placebo (very low certainty).
1 finding from 1 review
Pre‐eclampsia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes pre‐eclampsia compared with placebo (very low certainty).
1 finding from 1 review
Adverse events in the mother ‐ Bleeding · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes adverse events in the mother ‐ Bleeding compared with placebo (very low certainty).
1 finding from 1 review
Venous thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Arterial thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pregnancy loss · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes pregnancy loss compared with placebo (very low certainty).
1 finding from 1 review
Preterm delivery of a live infant · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes preterm delivery of a live infant compared with placebo (very low certainty).
1 finding from 1 review
Intrauterine growth restriction · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes intrauterine growth restriction compared with placebo (very low certainty).
1 finding from 1 review
Adverse events in the child ‐ Congenital malformations · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes adverse events in the child ‐ Congenital malformations compared with placebo (very low certainty).
1 finding from 1 review